Kazimierz Halaburda
0000-0003-3624-785X
Institute of Hematology and Transfusion Medicine
148 papers found
Refreshing results…
High efficacy of dasatinib in maintenance therapy after allogeneic haematopoietic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
The impact of gut colonization by antibiotic-resistant bacteria on the outcomes of allogeneic hematopoietic stem-cell transplantation: a retrospective, single-center study
Hematopoietic stem cell transplantation in secondary relapsed hemophagocytic lymphohistiocytosis,Przeszczepienie krwiotwórczych komórek macierzystych w nawrotowej wtórnej limfohistiocytozie hemofagocytarnej
Analysis of the shedding of three beta-herpesyiruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up
Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations
Real-Time PCR Analysis of Chimerism in T Cell Subsets as an Early Predictor of Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation
Beneficial effect of the CXCL12-3′A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors
Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group
An economic analysis of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of new onset type 1 diabetes
Role of Donor Activating KIR–HLA Ligand–Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients
The outcome of allogeneic stem cell transplantation in myelodysplastic syndrome is related to disease burden at transplant: a multicenter study of the Polish Adult Leukemia Group
Long term effects of immunoablation and hematopoietic stem cell transplantation in new-onset type 1 diabetes
Beneficial effect of the CXCL12-3 ' A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors
Mild chronic GvHD may alleviate the poor prognosis associated with FLT3-internal tandem duplication in adult patients with AML following alloHSCT with myeloablative conditioning in first complete remission
Downward Resetting of Donor Nk Cell Licensing Status After HSCT Is Highly Adverse for Recipient Survival and Disease Relapse or Progression
Increased efficacy of intermediate-dose cytarabine plus G-CSF compared to DHAP plus G-CSF for stem cell mobilization in patients with lymphoma: an analysis from the Polish Lymphoma Research Group
Comparison of two fludarabine-based reduced-intensity conditioning regimens in elderly or infirm patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation
Advances in transplantation of hematopoietic stem cells from haploidentical donors,Postępy w przeszczepieniach krwiotwórczych komórek macierzystych od dawców haploidentycznych
Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation
Incidence of Adenoviral DNAemia in Polish Adults Undergoing Allogeneic Haematopoietic Stem Cell Transplantation
Missing publications? Search for publications with a matching author name.